Neelima et al. [42] underscored its ability to induce a dominant Th1 response and MUC1-specific cytotoxic T lymphocytes (CTLs), highlighting its potential in the fight against NSCLC. This evidence concerns the gene MUC1 and non-small cell lung carcinoma.